473923-56-7

Basic information

• Product Name: 3-HYDROXYMETHYL-MORPHOLINE-4-CARBOXYLIC ACID TERT-BUTYL ESTER
• Synonyms: Di-tert-butyl morpholine-3,4-dicarboxylate;3-HYDROXYMETHYL-MORPHOLINE-4-CARBOXYLIC ACID TERT-BUTYL ESTER;1-N-BOC-2-HYDROXYMETHYL MORPHOLINE;4-BOC-3-HYDROXYMETHYL-MORPHOLINE;N-BOC-3-hydroxymethylmorpholine;tert-Butyl 3-(hydroxymethyl)morpholine-4-carboxylate;4-Morpholinecarboxylic acid, 3-(hydroxymethyl)-, 1,1-dimethylethyl ester
• CAS NO: 473923-56-7
• Molecular Formula: C₁₀H₁₉NO₄
• Molecular Weight: 217.26
• Mol File: 473923-56-7.mol
• Article Data: 9

Chemical Properties

• Boiling Point: 320.7°C at 760 mmHg
• Flash Point: 147.8°C
• Appearance: /
• Density: 1.118g/cm³
• Vapor Pressure: 2.53E-05mmHg at 25°C
• Refractive Index: 1.474
• Storage Temp.: 2-8°C
• PKA: 14.85±0.10(Predicted)
• CAS DataBase Reference: 3-HYDROXYMETHYL-MORPHOLINE-4-CARBOXYLIC ACID TERT-BUTYL ESTER(CAS DataBase Reference)
• NIST Chemistry Reference: 3-HYDROXYMETHYL-MORPHOLINE-4-CARBOXYLIC ACID TERT-BUTYL ESTER(473923-56-7)
• EPA Substance Registry System: 3-HYDROXYMETHYL-MORPHOLINE-4-CARBOXYLIC ACID TERT-BUTYL ESTER(473923-56-7)

Safety Data

• Hazardous Substances Data: 473923-56-7(Hazardous Substances Data)

Usage

General Description

3-Hydroxymethyl-morpholine-4-carboxylic acid tert-butyl ester is a chemical compound with the molecular formula C11H21NO4. It is a tert-butyl ester derivative of 3-hydroxymethyl-morpholine-4-carboxylic acid and is used as a building block in organic synthesis. 3-HYDROXYMETHYL-MORPHOLINE-4-CARBOXYLIC ACID TERT-BUTYL ESTER is mainly used in the pharmaceutical industry as an intermediate for the synthesis of various drugs and medications. Its tert-butyl ester group provides stability to the compound and makes it easier to handle and store. 3-Hydroxymethyl-morpholine-4-carboxylic acid tert-butyl ester is a valuable chemical in the field of drug development and manufacturing.

InChI:InChI=1/C10H19NO4/c1-10(2,3)15-9(13)11-4-5-14-7-8(11)6-12/h8,12H,4-7H2,1-3H3

Upstream product

• 24424-99-5 di-tert-butyl dicarbonate 
• 955400-09-6 morpholin-3-yl methanol hydrochloride 
• 110167-20-9 4-benzyl-3-(hydroxymethyl)morpholine 
• 106910-79-6 (RS)-4-benzyl-5-oxomorpholine-3-carboxylic acid 
• 1269446-63-0 morpholine-3,4-dicarboxylic acid 4-tert-butyl ester 
• 212650-45-8 morpholine-3,4-dicarboxylic acid 4-tert-butyl ester 3-methyl ester 
• 106910-83-2 (rac)-3-hydroxymethylmorpholine 
• 77873-76-8 morpholine-3-carboxylic acid 
• 212650-43-6 4-(tert-butoxycarbonyl)morpholine-3-carboxylic acid 

Downstream Products

• 833474-06-9 tert-butyl 3-formylmorpholine-4-carboxylate 
• 1159598-86-3 4-methyl-3-(hydroxymethyl)morpholine 
• 1159598-80-7 3-[4-(4-fluorophenyl)-piperazine-1-carbonyloxymethyl]-morpholine-4-carboxylic acid tert-butyl ester 
• 1159598-91-0 3-[4-(2,4-difluoro-phenyl)-piperazine-1-carbonyloxymethyl]-morpholine-4-carboxylic acid tert-butyl ester 
• 1159598-89-6 3-(4-phenyl-piperazine-1-carbonyloxymethyl)-morpholine-4-carboxylic acid tert-butyl ester 
• 106910-83-2 (rac)-3-hydroxymethylmorpholine 
• 1620510-51-1 [(3R)-4-methylmorpholin-3-yl]methanol 
• 1398396-53-6 N-((R)-1-(naphthalen-1-yl)ethyl)-4-phenylmorpholine-3-carboxamide 
• 1398397-93-7 3-((((R)-1-(naphthalen-1-yl)ethyl)amino)methyl)-N-phenylmorpholine-4-carboxamide 
• 1398397-88-0 3-((((R)-1-(naphthalen-1-yl)ethyl)amino)methyl)-N-phenylmorpholine-4-carboxamide 

Relevant articles and documents

DIHYDROPYRIMIDINE COMPOUND AND PREPARATION METHOD AND USE THEREOF

The present invention relates to a dihydropyrimidine compound having an antiviral activity, a pharmaceutical composition comprising same, a preparation method therefor and the uses thereof in the prevention or treatment of viral diseases including, but no

8-Substituted isoquinoline derivative and the use thereof

The present invention relates to a compound represented by the following formula (1): wherein D1, A1, D2, R1, D3, and R2 each have the same meaning as defined in the present specification or a salt thereof. The compound represented by the formula (1) or a salt thereof has an IKKβ inhibiting activity and the like and is useful for the prevention and/or treatment of IKKβ-associated diseases or symptoms and the like.

NEW BRADYKININ B1 ANTAGONISTS

The invention relates to compounds of formula (I), wherein R1 to R5 and X1 to X4, n and m have the meaning as cited in the description and the claims. Said compounds are useful as Bradykinin B1 antagonists. The